...
首页> 外文期刊>Medicine. >Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study
【24h】

Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study

机译:一项全国性队列研究:影响初始内镜止血后慢性肾脏病消化性溃疡出血结果的危险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Patients with chronic kidney disease (CKD) who had peptic ulcer bleeding (PUB) may have more adverse outcomes. This population-based cohort study aimed to identify risk factors that may influence the outcomes of patients with CKD and PUB after initial endoscopic hemostasis. Data from 1997 to 2008 were extracted from the National Health Insurance Research Database in Taiwan. We included a cohort dataset of 1 million randomly selected individuals and a dataset of patients with CKD who were alive in 2008. A total of 18,646 patients with PUB were screened, and 1229 patients admitted for PUB after endoscopic hemostasis were recruited. The subjects were divided into non-CKD (n = 1045) and CKD groups (n = 184). We analyzed the risks of peptic ulcer rebleeding, sepsis events, and mortality among in-hospital patients, and after discharge. Results showed that the rebleeding rates associated with repeat endoscopic therapy (11.96% vs 6.32%, P = 0.0062), death rates (8.7%, vs 2.3%, P<0.0001), hospitalization cost (US$ 5595 +/- 7200 vs US$2408 +/- 4703, P<0.0001), and length of hospital stay (19.6 +/- 18.3 vs 11.2 +/- 13.1, P<0.0001) in the CKD group were higher than those in the non-CKD group. The death rate in the CKD group was also higher than that in the non-CKD group after discharge. The independent risk factor for rebleeding during hospitalization was age (odds ratio [OR], 1.02; P = 0.0063), whereas risk factors for death were CKD (OR, 2.37; P = 0.0222), shock (OR, 2.99; P = 0.0098), and endotracheal intubation (OR, 5.31; P<0.0001). The hazard ratio of rebleeding risk for aspirin users after discharge over a 10-year follow-up period was 0.68 (95% confidence interval [CI]: 0.45-0.95, P = 0.0223). On the other hand, old age (P<0.0001), CKD (P = 0.0090), diabetes (P = 0.0470), and congestive heart failure (P = 0.0013) were the independent risk factors for death after discharge. In-hospital patients with CKD and PUB after endoscopic therapy had higher recurrent bleeding, infection, and mortality rates, and the need for second endoscopic therapy. Age was the independent risk factor for recurrent bleeding during hospitalization. After being discharged with a 10-year follow-up period, nonaspirin user was a significant factor for recurrent bleeding.
机译:患有消化性溃疡出血(PUB)的慢性肾脏病(CKD)患者可能会有更多不良后果。这项基于人群的队列研究旨在确定可能在内窥镜止血后影响CKD和PUB患者预后的危险因素。 1997年至2008年的数据摘自台湾国家健康保险研究数据库。我们纳入了100万随机选择的队列数据集和2008年存活的CKD患者数据集。共筛查了18646例PUB患者,招募了内镜止血后入院的1229例PUB患者。将受试者分为非CKD组(n = 1045)和CKD组(n = 184)。我们分析了住院患者以及出院后消化性溃疡再出血,败血症事件和死亡率的风险。结果显示重复内镜治疗的再出血率(11.96%vs 6.32%,P = 0.0062),死亡率(8.7%,vs 2.3%,P <0.0001),住院费用(US $ 5595 +/- 7200 vs US CKD组的$ 2408 +/- 4703,P <0.0001)和住院时间(19.6 +/- 18.3 vs 11.2 +/- 13.1,P <0.0001)高于非CKD组。出院后CKD组的死亡率也高于非CKD组。住院期间再出血的独立危险因素是年龄(优势比[OR],1.02; P = 0.0063),而死亡的危险因素是CKD(OR,2.37; P = 0.0222),休克(OR,2.99; P = 0.0098) )和气管插管(OR,5.31; P <0.0001)。十年随访期间出院后阿司匹林使用者再出血风险的危险比为0.68(95%置信区间[CI]:0.45-0.95,P = 0.0223)。另一方面,老年(P <0.0001),CKD(P = 0.0090),糖尿病(P = 0.0470)和充血性心力衰竭(P = 0.0013)是出院后死亡的独立危险因素。住院内镜治疗后患有CKD和PUB的患者复发出血,感染和死亡率更高,并且需要第二次内镜治疗。年龄是住院期间再次出血的独立危险因素。经过10年的随访,出院后服用非阿司匹林是复发性出血的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号